SynthesisFrontiers in oncology2021

Immune-Related Adverse Events Predict the Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Patients: A Meta-Analysis.

Donghui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.